|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0012091,
umls-concept:C0019552,
umls-concept:C0022742,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0036043,
umls-concept:C0178602,
umls-concept:C0205390,
umls-concept:C1176415,
umls-concept:C1384584
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-8-30
|
|
pubmed:abstractText |
To compare the efficacy and tolerability of the novel cyclooxygenase 2-selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
549-57
|
|
pubmed:dateRevised |
2009-11-6
|
|
pubmed:meshHeading |
pubmed-meshheading:15334426-Aged,
pubmed-meshheading:15334426-Cyclooxygenase Inhibitors,
pubmed-meshheading:15334426-Diclofenac,
pubmed-meshheading:15334426-Double-Blind Method,
pubmed-meshheading:15334426-Female,
pubmed-meshheading:15334426-Health Status,
pubmed-meshheading:15334426-Humans,
pubmed-meshheading:15334426-Male,
pubmed-meshheading:15334426-Middle Aged,
pubmed-meshheading:15334426-Organic Chemicals,
pubmed-meshheading:15334426-Osteoarthritis, Hip,
pubmed-meshheading:15334426-Osteoarthritis, Knee,
pubmed-meshheading:15334426-Pain,
pubmed-meshheading:15334426-Placebos,
pubmed-meshheading:15334426-Questionnaires,
pubmed-meshheading:15334426-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial.
|
|
pubmed:affiliation |
Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA. tjs@northwestern.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|
